Healthcare and Biotech Sector Archives - Page 2 of 2 - Richmond Club

Category: Healthcare and Biotech Sector

DelMar Pharmaceuticals Develops and Commercializes Proven Cancer Therapies

Company: DelMar Pharmaceuticals, Inc Symbol: NASDAQ: DMPI Length: 00:26:11 Presenter: Jeffrey Bacha, Chairman Occasion: Richmond Club Lunch, Toronto DelMar Pharmaceuticals, Inc. was founded in 2010 to develop and commercialize proven cancer therapies in new orphan drug indications where patients are failing modern targeted or biologic treatments. Product Information The Company’s lead asset, VAL-083, is currently undergoing […]
Read more

VolitionRx Addresses Need for Cancer Diagnostics

Company: VolitionRx Ltd. Symbol: NYSE MKT: VNRX Length: 00:23:42 Presenter: Cameron Reynolds, President and CEO Occasion: Richmond Club Lunch, Toronto VolitionRx’s mission is to address the need for non-invasive, accurate, and cost-effective diagnostics for cancer and other conditions, with our NuQ® suite of products. About VolitionRx VolitionRx was established in 2010, when our team of […]
Read more

Aphria Focusses on Medical Marijuana Business

Company: Aphria Inc Symbol: CVE: APH Length: 00:37:21 Presenter: Vic Neufeld, Chairman Occasion: Richmond Club Lunch, Toronto Aphria, a company continued under the laws of the Province of Ontario and based in Leamington, Ontario, is in the business of producing, supplying and selling medical marijuana pursuant to the “Marihuana for Medical Purposes Regulations” (the “MMPR”). Under […]
Read more

Pressure BioSciences Well Positioned to Take Advantage of Cancer Moonshot

Company: Pressure BioSciences, Inc Symbol: OTCQB: PBIO Length: 00:25:37 Presenter: Richard T. Schumacher, President ,CEO & Founder Occasion: Richmond Club Lunch, Toronto We are a life sciences company focused on the development and commercialization of a novel, enabling, platform technology called pressure cycling technology (“PCT”). PCT uses cycles of hydrostatic pressure between ambient and ultra-high […]
Read more

Resverlogix Modulates Protein Production with Epigenetic Platform Technology

Company: Resverlogix Corp. Symbol: TSX: RVX Length: 00:20:29 Presenter: Donald J. McCaffrey, President and CEO Occasion: Richmond Club Lunch, Toronto Resverlogix Corp. (TSX: RVX) is a clinical stage cardiovascular company with an epigenetic platform technology that modulates protein production. Resverlogix is developing RVX-208, a first-in-class small molecule for the treatment of atherosclerosis. RVX-208 is the […]
Read more

Oncolytics Biotech Focused on Oncolytic Viruses for Cancer Therapeutics

Company: Oncolytics Biotech Inc. Symbol: TSX: ONC, OTCQX: ONCYF Length: 00:23:53 Presenter: Dr. Brad Thompson, Chairman, President & CEO Occasion: Richmond Club Lunch, Toronto Oncolytics Biotech Inc. is focused on the development of oncolytic viruses for use as cancer therapeutics. The Company’s lead product, REOLYSIN®, a proprietary formulation of the human reovirus, is currently in […]
Read more

MedX a Global Leader in Low Level Laser and Light Therapy Technologies

Company: MedX Health Corp Symbol: Private Length: 00:17:28 Presenter: Rob von der Porten, President & CEO Occasion: Richmond Club Lunch, Toronto MedX is a 12 year old Canadian company that is a global leader in the design, manufacturing and distribution of quality low level laser and light therapy technologies for use in numerous medical settings, […]
Read more
  • 0800-123456 (24/7 Support Line)
  • 6701 Democracy Blvd, Suite 300, USA